The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1177
March 1, 2004
View Complete Issue         Table of Contents 2019 
An Injectable Hyaluronic Acid (Restylane) for Wrinkles
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
An Injectable Hyaluronic Acid (Restylane) for Wrinkles
March 1, 2004 (Issue: 1177)
An injectable gel of hyaluronic acid (Restylane) has been approved by the FDA for correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. Manufactured by Q-Med AB, a Swedish company, it has been used outside the US since...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: An Injectable Hyaluronic Acid (Restylane) for Wrinkles
Article code: 1177c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.